Research Article

Transcatheter Mitral Valve Replacement in High-Surgical Risk Patients: A Single-Center Experience and Outcome

Table 3

Echocardiographic assessments of valvular function throughout follow-up.

TMVR total N: 64Groups-value
TMViV N: 35 (55%)TMViR N: 16 (25%)TMViMAC N: 13 (20%)

MV mean Pg (mmHg)
Preprocedure14.3 ± 5.314.8 ± 5.112.1 ± 4.615.5 ± 6.40.162
Immediately/In-hospital4.4 ± 1.24.2 ± 1.34.4 ± 1.04.6 ± 1.00.618
<0.001<0.001<0.001<0.001
3-month postprocedure4.7 ± 1.34.9 ± 1.44.6 ± 1.05.1 ± 1.40.554
<0.001<0.001<0.001<0.001
6-month postprocedure5.4 ± 1.64.9 ± 1.75.4 ± 1.55.5 ± 1.40.438
<0.001<0.001<0.001<0.001

MR
Preprocedure0.319
 (i) Trivial/Mild3 (4.7%)3 (8.6%)0 (0.0%)0 (0.0%)
 (ii) Moderate15 (23.4%)8 (22.7%)5 (31.3%)2 (15.4%)
 (iii) Sever26 (40.6%)10 (28.6%)7 (43.8%)9 (69.2%)
Immediately/In-hospital (Trivial/Mild)10 (15.6%)3 (8.6%)5 (31.3%)2 (15.4%)0.215
<0.001<0.001<0.0010.001
3-month postprocedure (trivial/mild/moderate)11 (17.2%)3 (8.6%)6 (37.5%)2 (15.4%)0.074
<0.001<0.001<0.0010.002
6-month postprocedure (trivial/mild/moderate)17 (26.6%)9 (25.7%)6 (37.5%)2 (15.4%)0.670
<0.001<0.001<0.0010.002

LVEF (%)
Preprocedure48.8 ± 15.849.3 ± 13.834.4 ± 11.465.2 ± 5.8<0.001
Immediately/In-hospital50.7 ± 14.851.6 ± 12.936.8 ± 10.765.5 ± 5.9<0.001
<0.001<0.0010.0060.610
3-month postprocedure52.3 ± 14.052.7 ± 12.240.3 ± 11.865.8 ± 62<0.001
<0.001<0.001<0.0010.292
6-month postprocedure53.8 ± 13.054.6 ± 11.142.4 ± 11.965.9 ± 5.6<0.001
<0.001<0.001<0.0010.157

ESPAP (mm Hg)
Pre-procedure67.9 ± 18.869.7 ± 19.361.6 ± 20.470.8 ± 14.60.302
Immediately/In-hospital61.0 ± 15.460.5 ± 14.356.6 ± 17.467.5 ± 14.30.05
<0.001<0.0010.0380.072
3-month postprocedure55.0 ± 15.152.6 ± 12.750.8 ± 16.766.5 ± 14.60.006
<0.001<0.0010.0020.063
6-month postprocedure51.7 ± 13.648.8 ± 9.847.7 ± 14.666.0 ± 14.70.001
<0.001<0.0010.0010.059

LVOT Pg (mmHg)
Pre-procedure3.14 ± 1.82.7 ± 1.82.7 ± 1.34.9 ± 0.9<0.001
Immediately/In-hospital4.0 ± 1.83.0 ± 1.43.6 ± 1.56.1 ± 0.8<0.001
<0.0010.0860.59<0.001
3-month postprocedure4.1 ± 1.93.1 ± 1.43.9 ± 1.36.45 ± 1.1<0.001
<0.0010.0550.057<0.001
6-month postprocedure4.4 ± 2.23.1 ± 1.54.0 ± 1.37.5 ± 1.9<0.001
<0.0010.0610.053<0.001

ESPAP: estimated systolic pulmonary artery pressure, LVEF: left ventricular ejection fraction, LVOT: left ventricular outflow tract, MR: mitral regurgitation, MV: mitral valve, Pg: pressure gradient, TMVR: transcatheter mitral valve replacement, TMViV: transcatheter mitral valve-in-valve, TMViR: transcatheter mitral valve-in-ring, TMViMAC: transcatheter mitral valve-in-mitral annular calcification.